
TNIK-IN-2
CAS No. 2754265-76-2
TNIK-IN-2( —— )
Catalog No. M28760 CAS No. 2754265-76-2
TNIK-IN-2 is an inhibitor Traf2- and Nck-interacting protein kinase (TNIK, IC50 = 1.33 μM)) which is a downstream signal protein of the Wnt/β-catenin pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTNIK-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionTNIK-IN-2 is an inhibitor Traf2- and Nck-interacting protein kinase (TNIK, IC50 = 1.33 μM)) which is a downstream signal protein of the Wnt/β-catenin pathway.
-
DescriptionTNIK-IN-2 is an inhibitor Traf2- and Nck-interacting protein kinase (TNIK, IC50 = 1.33 μM)) which is a downstream signal protein of the Wnt/β-catenin pathway.(In Vitro):In HCT116 cells, the IC50 value was 31.26 μM for TNIK.
-
In VitroTNIK-IN-2 (compound 1) inhibits TNIK, with an IC50 of 31.26 μM in HCT116 cells.
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2754265-76-2
-
Formula Weight373.4
-
Molecular FormulaC22H19N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cccc(NC(c(ccc(-c2cnc3[nH]ccc3c2)c2)c2OC)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kagenishi T, et al. MES Buffer Affects Arabidopsis Root Apex Zonation and Root Growth by Suppressing Superoxide Generation in Root Apex. Front Plant Sci. 2016;7:79. Published 2016 Feb 18.
molnova catalog



related products
-
YW2036
YW2036 is an inhibitor of Wnt signaling pathway.
-
WAY-328173
WAY-328173 is a Wnt/beta-catenin agonist.
-
Vantictumab
Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.